Pharmaceuticals
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. George Frey | Bloomberg | Getty Images Skyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new heights over the last year. […]
Read More
Judge bars ‘pharma bro’ Martin Shkreli from streaming Wu-Tang Clan album after suit says he copied it
Former drug company executive Martin Shkreli and his lead attorney Benjamin Brafman arrive at U.S. District Court for the fourth day of jury deliberations in his securities fraud trial in the Brooklyn borough of New York City, U.S., August 3, 2017. Amr Alfiky | Reuters A federal judge temporarily barred notorious “pharma bro” Martin Shkreli […]
Read More
Jim Cramer says the best is yet to come at Oracle — plus, his thoughts on 4 more stocks
Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Oracle : The tech giant had a mixed quarter. But it announced new artificial intelligence partnerships with Alphabet ‘s Google and Microsoft -backed OpenAI. Oracle also reported strong RPO, short for remaining performance obligation. RPO is what contracted […]
Read More
FDA advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, paving way for approval
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty […]
Read More
Roche alleges counterfeit diabetes medical devices were sold on Amazon
Roche Diabetes Care Inc. Accu-Chek brand glucose test strips are arranged for a photograph in the Brooklyn borough of New York, U.S., on Thursday, April 4, 2019. Alex Flynn | Bloomberg | Getty Images Roche, one of the world’s largest biotech companies, said “dangerous counterfeits” of its diabetes medical devices ended up for sale on […]
Read More
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Empty bottles of Moderna’s Covid-19 vaccine. Fred Tanneau | AFP | Getty Images Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. The biotech company is the first to release positive phase three data on a […]
Read More
Trump claims credit for Biden’s insulin price cap
President Joe Biden and former President Donald Trump 2024. Kevin Lamarque | Jay Paul | Reuters Former President Donald Trump on Saturday recognized that the price of insulin is lower under President Joe Biden, but he still wants voters to credit his own administration. “Low INSULIN PRICING was gotten for millions of Americans by me, and […]
Read More
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration on Friday expanded the approval of GSK‘s respiratory syncytial virus vaccine to adults ages 50 to 59 who are at increased risk of getting severely sick from the potentially lethal virus. The shot, called Arexvy, […]
Read More
Alphabet’s new CFO was in the middle of the GLP-1 growth. Now she’s onto generative AI
Alphabet incoming CFO Anat Ashkenazi, who invested 23 many years at Eli Lilly Eli Lilly Alphabet’s outgoing finance chief, Ruth Porat, spent the past calendar year and a fifty percent trying to assist her online firm navigate the generative synthetic intelligence increase. The human being who was just named her successor was knee-deep in a […]
Read More
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. Matthew Childs | Reuters LONDON — Shares of British pharmaceuticals giant GSK plunged 9% Monday, after a U.S. court ruled that scientific evidence could be presented as a stack of lawsuits relating to the discontinued heartburn drug Zantac move forward. […]
Read More